Search results
Health Benefits of Legumes
Health via Yahoo News· 2 hours agoResearch also suggests that people with high dietary fiber intake may be up to 21% less likely to develop colon cancer compared to people with low fiber...
What Happens When You Stop Taking Ozempic?
PureWow via Yahoo News· 1 day agoUnless you’ve been living under a rock, you’re likely familiar with Ozempic, the miracle weight loss drug that has made headlines, shown up in your news...
Metformin slows colorectal cancer growth using microRNAs, study finds
MedicalNewsToday via AOL· 4 days agoA new cell study has shown the common type 2 diabetes medication metformin alters levels of...
Massive surge in pre-diabetes as high blood sugar levels create timebomb
Daily Express· 6 days agoA record 3.6million people are at high risk of developing diabetes as the nation battles an obesity...
Paleo vs. Mediterranean Diet: Colorful Foods with Varying Flexibilities
Woman's World via Yahoo News· 10 hours agoYup, this means no bread (of any kind), rice, oatmeal, cheese, alcohol or even adding salt to season...
The amazing 12p pill that could help prevent and reverse type 2 diabetes
Daily Express· 5 days agoDiabetes is a serious and typically lifelong condition which causes your blood sugar levels to...
Tea vs. Coffee: How Do Their Health Benefits Compare?
Health via Yahoo News· 2 days agoBoth are rich in health-promoting compounds that may protect against many health conditions,...
Gateway - Quartz
Quartz· 1 hour agoNovo Nordisk responded today to the U.S. Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. The Ozempic maker denied wrongdoing ...
AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe latest development comes after the FDA approved AstraZeneca‘s Farxiga (dapagliflozin) for the...
Potential new treatment option for diabetic retinopathy could address the problem much earlier
Medical Xpress· 6 hours agoResearchers at the University of Oklahoma Health Sciences and Memorial Sloan Kettering (MSK) Cancer Center are studying a new, revolutionary treatment for diabetic retinopathy ...